OTHER · Unmapped registry intervention
discontinuation of ART
Find medicine records ·
Find other trials using this name
Clinical trial
Analytical Treatment Interruption in a Patient With HIV Post Allogeneic Stem Cell Transplantation From a CCR5 delta32 Homozygous Donor
NCT06582797
Drugs and interventions used in this trial
1 registeredThese interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.
No matching interventions in this trial.
Study at a glance
Registry-backedAnalytical Treatment Interruption in a Patient With HIV Post Allogeneic Stem Cell Transplantation From a CCR5 delta32 Homozygous Donor
Design: INTERVENTIONAL · Status: NOT YET RECRUITING · Phase: NA
Read study objectives, eligibility and outcome measures at ClinicalTrials.govAdvertisement
Conditions
HIV-1-infectionunresolved
Interventions
Sponsors & collaborators
University of Kansas Medical Centerlead sponsor
National Institutes of Health (NIH)collaborator
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT06582797 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.